Fentiman Is
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
-
- Breast Lesions and Carcinomas
Papers in
-
- Breast Cancer Treatment Studies 13
-
- Cancer and Skin Lesions 4
- Co-authors
- van Dongen JaJ. WinterAntoon LerutHarry BartelinkRichard SylvesterG OlthuisF MignoletMaira Caleffi
- Journals
- International Journal of Clinical Practice (4 papers)British Journal of Cancer (2 papers)European Journal of Cancer (1 paper)The Breast (1 paper)Bone (1 paper)
- Partner nations
- United KingdomNetherlandsPoland
In The Last Decade
Fentiman Is
23 papers receiving 755 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 425
- Pathology and Forensic Medicine 295
- Orthopedics and Sports Medicine 124
- Oncology 264
- Radiation 56
Countries citing papers authored by Fentiman Is
This map shows the geographic impact of Fentiman Is's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fentiman Is with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fentiman Is more than expected).
Fields of papers citing papers by Fentiman Is
This network shows the impact of papers produced by Fentiman Is. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fentiman Is. The network helps show where Fentiman Is may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fentiman Is, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 1 | |
| 2 | 2002 | 14 | |
| 3 | 2001 | 21 | |
| 4 | Hormone replacement therapy and breast cancer. | 1998 | 2 |
| 5 | 1998 | 74 | |
| 6 | 1997 | 2 | |
| 7 | 1994 | 13 | |
| 8 | Male breast cancer. | 1993 | 4 |
| 9 | Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. | 1992 | 344 |
| 10 | 1992 | 10 | |
| 11 | 1990 | 118 | |
| 12 | 1989 | 51 | |
| 13 | Studies of tamoxifen in women with mastalgia. | 1989 | 7 |
| 14 | A comparison of the fatty acid profiles of subcutaneous fat from women with breast cancer, benign breast disease and normal controls. | 1988 | 8 |
| 15 | Tamoxifen: use in benign conditions. | 1988 | 0 |
| 16 | Adjuvant androgen treatment of operable breast cancer--a 20 year analysis. | 1987 | 3 |
| 17 | In situ ductal carcinoma of the breast: implications of disease pattern and treatment. | 1986 | 64 |
| 18 | Conservative treatment of early breast cancer. | 1986 | 1 |
| 19 | Surgical options for the treatment of operable breast cancer. | 1985 | 3 |
| 20 | Cell communication in breast cancer. | 1980 | 4 |
About Fentiman Is
Fentiman Is is a scholar working on Cancer Research, Dermatology, Pathology and Forensic Medicine, Oncology and Genetics, having authored 24 papers that have together received 789 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (8 papers), Cancer and Skin Lesions (4 papers), BRCA gene mutations in cancer (3 papers), Cancer Risks and Factors (3 papers), Cancer Treatment and Pharmacology (3 papers), Male Breast Health Studies (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Cancer Research (425 citations), Pathology and Forensic Medicine (295 citations), Orthopedics and Sports Medicine (124 citations), Oncology (264 citations) and Radiation (56 citations). Fentiman Is has collaborated with scholars based in United Kingdom, Netherlands and Poland. Frequent co-authors include van Dongen Ja, J. Winter, Antoon Lerut, Harry Bartelink, Richard Sylvester, G Olthuis, F Mignolet, Maira Caleffi, I. Fogelman and A. Rodin. Their work appears in journals such as International Journal of Clinical Practice, British Journal of Cancer, European Journal of Cancer, The Breast and Bone.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.